Prevention of Seasonal Affective Disorder

Phase 3

Completed

• Conditions: Seasonal Affective Disorder (SAD)

• Registration Number: NCT00046449
• Lead Sponsor: GlaxoSmithKline

Brief Summary

A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Detailed Description

Not available

Study Timeline

• Study Start: 2002-09
• Study First Submitted: 2002-09-30
• Study First Submitted QC: 2002-10-01
• Study First Posted: 2002-10-02
• Primary Completion: 2003-06
• Study Completion: 2003-06
• Status Verified: 2015-06
• Last Update Submitted: 2015-06-02
• Last Update Posted: 2015-06-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(Patient must meet these criteria in order to be eligible for this study.)

• Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

Exclusion Criteria

(Patient cannot meet these criteria in order to be eligible for this study.)

• Patient has a current or past history of seizure disorder or brain injury.
• Patient has a history or current diagnosis of anorexia nervousa or bulimia.
• Patient has recurrent summer depression more frequently than winter depression.
• Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
• Patient has initiated psychotherapy within the last 3 months.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (2)

Study SIte; 🇺🇸 Greenwood, Indiana, United States

Study Site; 🇨🇦 Hull, Quebec, Canada